Evra 6 Mg/600 Mcg 3 Patches

EVRA® should not be used in women who currently have the following conditions: Thrombophlebitis, and thromboembolic disorders. History of deep vein thrombophlebitis or thromboembolic disorders. Known thrombophilic conditions. Cerebrovascular or coronary artery disease. Valvular heart disease with complications103. Severe hypertension (persistent values ​​of 160+/100+ mmHg). Diabetes with vascular involvement. Migraine with focal aura. Known or suspected breast cancer. Endometrial carcinoma or other known or suspected estrogen-dependent neoplasm. Undiagnosed abnormal transvaginal bleeding. Family history of cholestatic jaundice, or chronic idiopathic jaundice. Acute or chronic hepatocellular disease with abnormal liver function. Hepatic adenomas or carcinomas. A known or suspected pregnancy. Hypersensitivity to any of the components of this product.